TICKERNERD
Menu
ADUSADUSHealthcare · Medical Care Facilities

ADUS Stock Forecast: Addus HomeCare Corp. Price Predictions for 2026-2027

Last close, 24 Sept 2026
$114
−0.77% on the day

The 14 Wall Street analysts covering Addus HomeCare Corp. hold a median 12-month price target of $135 — +18.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 95 of 100 as at 23 Sept 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$2.1B
Ticker Nerd rank
95 / 100
Median analyst target
$135
Analysts covering
14
Revenue$377.4M+8.0% y/y
Operating income$38.9M
Net income$27.6M
Free cash flow$38.7M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−3.4%
1M
−5.6%
YTD
+6.2%
1Y
−2.4%
From 52W high
−7.1%
From 52W low
+28.9%
$88
$123
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ADUS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Addus HomeCare Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 23 Sept 2026
95 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
92
Growth
82
Issuance
81
Quality
81
Value
79
Revisions
74
Accruals
64
Momentum
63
Size
34

Volatility (92): The share price has been relatively steady.

Momentum (63): The shares have been drifting down relative to others.

Size (34): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ADUS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ADUS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$80$100$120$140$160Oct 25Jan 26Apr 26Jul 26ADUSHigh $155Median $135Low $96

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says14 analysts
11 Buy2 Hold1 Sell
Low $96Median $135High $155

The green dot is the last close — the median target sits +18.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 2 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
14 Sept 2026B of A SecuritiesDowngradeNeutral$140 → $125
5 Aug 2026RBC CapitalMaintainsOutperform$130 → $134
5 Aug 2026RBC CapitalMaintainsOutperform—
9 July 2026BarclaysMaintainsUnderweight$92 → $96
9 July 2026BarclaysMaintainsUnderweight—
18 May 2026CitizensReiteratesMarket Outperform—
15 May 2026BarclaysMaintainsUnderweight—
6 May 2026CitizensMaintainsMarket Outperform—
25 Mar 2026BarclaysMaintainsUnderweight—
25 Feb 2026Stephens & Co.MaintainsOverweight—
24 Feb 2026BarclaysMaintainsUnderweight—
13 Nov 2025BMO CapitalInitiatesMarket Perform—
7 Nov 2025RBC CapitalMaintainsOutperform—
5 Nov 2025TD CowenMaintainsBuy—
4 Nov 2025BarclaysMaintainsUnderweight—
3 Sept 2025Stephens & Co.ReiteratesOverweight—
2 Sept 2025UBSInitiatesBuy—
22 Aug 2025RBC CapitalMaintainsOutperform—
19 Aug 2025BarclaysMaintainsUnderweight—
6 Aug 2025TD CowenMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ADUS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ADUS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 24 Sept 2026, Addus HomeCare Corp. returned −2.4% against +17.3% for the S&P 500, dividends included.

ADUS vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120Oct 25Jan 26Apr 26Jul 26ADUSS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ADUS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.8%
Analysts raising
11
Analysts cutting
3
Fundamentals

Addus HomeCare Corp. (ADUS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
20.2×

Cheaper than 37% of US stocks

Price / sales
1.5×

Cheaper than 60% of US stocks

Price / book
1.8×

Cheaper than 48% of US stocks

EV / EBITDA
13.2×

Cheaper than 27% of US stocks

Growth & margins
Revenue growth (YoY)
8.0%

Higher than 47% of US stocks

Earnings growth (YoY)
25.2%

Higher than 62% of US stocks

Gross margin
32.2%

Higher than 37% of US stocks

Operating margin
9.7%

Higher than 63% of US stocks

Net margin
7.1%

Higher than 65% of US stocks

Returns & dividend
Return on equity
9.7%

Higher than 63% of US stocks

Return on assets
6.3%

Higher than 82% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Addus HomeCare Corp. (ADUS) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Addus HomeCare Corp. has a market value of $2.1B and an enterprise value of $2.1B.

  • Revenue in the twelve months to 30 June 2026: $1.5B. The latest quarter grew 8.0% year on year.

  • Net income over the same four quarters: $105.3M, a 7.1% net margin.

  • Diluted earnings per share, trailing twelve months: $5.67.

  • Free cash flow in the twelve months to 30 June 2026: $154.8M.

  • Shares outstanding: 18.7M.

  • Trailing P/E: 20.2×; forward P/E: 15.3× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Addus HomeCare Corp. employs 5,982 people — $247K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 24 Sept 2026

Data provided by Twelve Data

Peers

ADUS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
ADUSAddus HomeCare Corp.$2.1B
95
MDPediatrix Medical Group, Inc.$2.1B
99
SGRYSurgery Partners, Inc.$1.9B
43
SNDASonida Senior Living, Inc.$1.8B
27
ACHCAcadia Healthcare Co., Inc.$2.6B
55
BKDBrookdale Senior Living, Inc.$2.7B
75
ASTHAstrana Health, Inc.$1.7B
64

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Addus HomeCare Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ADUS news & analysis

Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare

Business Wire · 14 Sept 2026positive

Addus HomeCare announced a definitive agreement to acquire the personal care division of AccentCare, excluding its New York operations and its hospice and home health businesses, for an anticipated purchase price of approximately $275.0 million after customary adjustments.

Why it matters — This acquisition would expand Addus's personal care services footprint outside New York, potentially broadening its home care operations.

Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference

Business Wire · 8 Sept 2026neutral

Addus HomeCare announced that CFO Brian Poff and Interim COO Brad Bickham will participate in the 2026 Jefferies Healthcare Services and Technology Conference, scheduled for September 14-15, 2026, in Nashville, Tennessee. A live broadcast and replay of the company's presentation will be available.

Why it matters — The conference participation gives ADUS executives a platform to present the company's business to healthcare investors and analysts.

Addus HomeCare (ADUS) Just Flashed Golden Cross Signal: Do You Buy?

Zacks Investment Research · 12 Aug 2026positive

Addus HomeCare Corporation reached a significant support level, and its 50-day simple moving average broke out above its 200-day moving average, a technical pattern known as a "golden cross." According to Zacks Investment Research, this could make the stock a good pick from a technical perspective.

Why it matters — A golden cross signal at a key support level is a commonly watched technical indicator that Addus HomeCare watchers may track as a marker of momentum.

Addus HomeCare Announces Departure of Heather Dixon and Return of Brad Bickham as Chief Operating Officer on an Interim Basis

Business Wire · 10 Aug 2026negative

Addus HomeCare announced that Heather Dixon has left her role as President and Chief Operating Officer, and former President and COO Brad Bickham has returned as interim COO for a one-year period.

Why it matters — A sudden leadership change in a key executive role, even with an experienced interim replacement, can signal organizational disruption that investors and analysts will monitor closely.

ADUS vs. ELAN: Which Stock Is the Better Value Option?

Zacks Investment Research · 6 Aug 2026neutral

Zacks Investment Research published a piece comparing Addus HomeCare (ADUS) to Elanco Animal Health (ELAN), asking which of the two stocks currently offers value investors a better deal. Both are framed as stocks of interest to investors in medical outpatient and home healthcare.

Why it matters — The comparison highlights ADUS's valuation in relation to another company, which matters to ADUS watchers tracking how the stock is positioned for value-oriented investors.

FAQ

Frequently asked questions about ADUS stock

What is the ADUS stock price forecast for 2026-2027?

The 14 Wall Street analysts covering Addus HomeCare Corp. have a median 12-month price target of $135, with estimates ranging from $96 to $155. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ADUS stock a buy right now?

Of the 14 analysts covering Addus HomeCare Corp., 11 rate it a Buy, 2 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Addus HomeCare Corp. 95 out of 100 across roughly 4,600 US stocks as at 23 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ADUS?

As at 23 Sept 2026, Addus HomeCare Corp. ranks 95 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (92 of 100).

Will ADUS stock go up?

No one can know that. What the data says: the median 12-month target from 14 analysts implies +18.4% from the last close, and Ticker Nerd's factor model ranks Addus HomeCare Corp. 95 out of 100 as at 23 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ADUS stock forecast for 2030?

No analyst covering Addus HomeCare Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ADUS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $96 to $155 over the next 12 months.

How has ADUS stock performed over the past year?

Addus HomeCare Corp. returned -2.4% over the 12 months to 24 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Addus HomeCare Corp. do?

Addus HomeCare Corporation is a U.S. healthcare services company focused on home-based care for elderly, chronically ill, disabled, and medically fragile individuals.

What is the latest news on ADUS?

The most recent item we track (Business Wire, 14 Sept 2026): "Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare". Addus HomeCare announced a definitive agreement to acquire the personal care division of AccentCare, excluding its New York operations and its hospice and home health businesses, for an anticipated purchase price of approximately $275.0 million after customary adjustments.

Company

About Addus HomeCare Corp.

Addus HomeCare Corporation is a U.S. healthcare services company focused on home-based care for elderly, chronically ill, disabled, and medically fragile individuals. Addus HomeCare Corporation provides personal care, hospice, and home health services designed to support daily living, comfort, and clinical needs in the home setting. Its personal care services include non-medical assistance with activities such as bathing, grooming, dressing, meal support, and medication reminders, while its hospice and home health offerings address end-of-life support and medically supervised care after illness or hospitalization. The company serves patients through a broad network of locations across multiple states and works with government agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare Corporation plays an important role in the home care market by helping clients remain in familiar surroundings while receiving essential support services.

CEO Mr. R. Dirk Allison CPA · 5,982 employees · United States · https://www.addus.com